NASDAQ:BDTX
Black Diamond Therapeutics Inc. Stock News
$4.87
-0.370 (-7.06%)
At Close: May 17, 2024
Black Diamond Therapeutics to Present at Upcoming Investor Conferences
07:45am, Tuesday, 23'rd Feb 2021
CAMBRIDGE, Mass. and NEW YORK, Feb. 23, 2021 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a precision oncology medicine company pioneering the discovery and development of smal
Black Diamond Therapeutics to Present at the BMO Biopharma Spotlight Series
04:15pm, Thursday, 11'th Feb 2021
CAMBRIDGE, Mass. and NEW YORK, Feb. 11, 2021 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a precision oncology medicine company pioneering the discovery and development of smal
Black Diamond Therapeutics Announces Appointment of Oncology Clinical Development Veteran Dr. Kapil Dhingra to Board of Directors
07:45am, Wednesday, 20'th Jan 2021
CAMBRIDGE, Mass. and NEW YORK, Jan. 20, 2021 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a precision oncology medicine company pioneering the discovery and development of smal
Black Diamond Therapeutics to Present at the J.P. Morgan 39th Annual Healthcare Conference
07:45am, Tuesday, 05'th Jan 2021
CAMBRIDGE, Mass. and NEW YORK, Jan. 05, 2021 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a precision oncology medicine company pioneering the discovery and development of smal
Black Diamond Therapeutics Provides Update on GBM Program and Presents Pre-Clinical Data at the 2020 SNO Annual Meeting
07:45am, Friday, 20'th Nov 2020
CAMBRIDGE, Mass. and NEW YORK, Nov. 20, 2020 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a precision oncology medicine company pioneering the discovery and development of sm
Black Diamond Therapeutics to Present at the Jefferies 2020 Virtual London Healthcare Conference
07:45am, Wednesday, 11'th Nov 2020
CAMBRIDGE, Mass. and NEW YORK, Nov. 11, 2020 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a precision oncology medicine company pioneering the discovery and development of smal
Black Diamond Therapeutics Reports Third Quarter 2020 Financial Results and Provides Corporate Update
07:45am, Tuesday, 10'th Nov 2020
CAMBRIDGE, Mass. and NEW YORK, Nov. 10, 2020 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a precision oncology medicine company pioneering the discovery and development of smal
Black Diamond Reports Second Quarter 2020 Results
10:46pm, Tuesday, 11'th Aug 2020
Black Diamond Group Limited ("Black Diamond", the "Company" or "we"), (TSX:BDI), a leading provider of space rental and workforce accommodation solutions, today
Black Diamond Therapeutics Reports Second Quarter 2020 Financial Results and Provides Corporate Update
11:45am, Tuesday, 11'th Aug 2020
•Obtained U.S. FDA Fast Track designation for BDTX-189 for the treatment of adult patients with a solid tumor harboring an allosteric HER2 mutation or an EGFR or HER2 Exon 20 insertion mutation �
Is a Surprise Coming for Black Diamond Therapeutics (BDTX) This Earnings Season?
12:42pm, Monday, 10'th Aug 2020
Black Diamond Therapeutics (BDTX) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Black Diamond Therapeutics (NASDAQ:REYN) Downgraded to “Sell” at ValuEngine
08:46am, Sunday, 09'th Aug 2020
Black Diamond Therapeutics (NASDAQ:REYN) was downgraded by analysts at ValuEngine from a “hold” rating to a “sell” rating in a note issued to investors on Friday, ValuEngine reports. A number
Black Diamond Therapeutics to Present at Upcoming Investor Conferences
11:45am, Wednesday, 05'th Aug 2020
CAMBRIDGE, Mass. and NEW YORK, Aug. 05, 2020 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a precision oncology medicine company pioneering the discovery and development of smal
Black Diamond Therapeutics Announces the Appointment of Fang Ni as Chief Business Officer
11:45am, Tuesday, 04'th Aug 2020
CAMBRIDGE, Mass. and NEW YORK, Aug. 04, 2020 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a precision oncology medicine company pioneering the discovery and development of smal
Noble Midstream Partners Reports Second-Quarter 2020 Results
12:00am, Monday, 03'rd Aug 2020
Noble Midstream Partners LP (NASDAQ: NBLX) (“Noble Midstream” or the “Partnership”) today reported second-quarter 2020 financial and operational resul
We're Not Very Worried About Black Diamond Therapeutics' (NASDAQ:BDTX) Cash Burn Rate
01:58pm, Thursday, 30'th Jul 2020
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
